Rogel Cancer Center, University of Michigan Medicine — Ann Arbor, Michigan

Rogel Cancer Center, University of Michigan Medicine is a clinical research site located in Ann Arbor, Michigan, United States 48109.

Crixeo Health Trust Score: 51/100 (POOR). This profile has not yet been claimed by the site owner.

Rogel Cancer Center, University of Michigan Medicine has participated in 1 clinical trials with 1 currently active.

Therapeutic areas: Metastatic Pancreatic Ductal Adenocarcinoma.

Sponsors: Agenus Inc..

Sponsor Feasibility Report

Trust Score: 51/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Rogel Cancer Center, University of Michigan Medicine?

Rogel Cancer Center, University of Michigan Medicine has a Crixeo Trust Score of 51/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Rogel Cancer Center, University of Michigan Medicine conducted?

Rogel Cancer Center, University of Michigan Medicine has 1 clinical trials on record, with 1 currently active. Their work covers Metastatic Pancreatic Ductal Adenocarcinoma.

Is Rogel Cancer Center, University of Michigan Medicine accredited by Crixeo Health?

Rogel Cancer Center, University of Michigan Medicine has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Rogel Cancer Center, University of Michigan Medicine?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.